Commercial

Scrip

Home / products-services / Commercialization / Scrip

Global pharmaceutical industry news that goes beyond the headlines

From licensing and clinical trials to competitor activity, stay current on business developments in your market.

Scrip delivers high-value commercial intelligence and analysis on the latest licensing opportunities, partnership deals, R&D activity, company developments and market access insights – providing all you need to understand the potential impact of market developments on your business.

Timely and tactical decision-making throughout the entire drug discovery, development and product life cycle value chain, empowers you to make more informed decisions faster – so you accelerate time to market, realize greater cost savings and stay ahead of the competition.

Industry news and insights

How it helps

Use Scrip’s focus on the strategic implications of global pharma news to fully understand what worldwide developments in the industry mean for your business.

With end-to-end coverage encompassing the whole of the drug discovery, development and product life cycle value chain, Scrip delivers analysis, news and insights across multiple therapy areas and product types.

A group of people standing around a laptop.

How it works

Make the right decisions for the long-term, backed by expert data, analysis and insight, robust interactive tools and expertise on call.

Company news in context: what industry developments really mean for strategy, next steps and the competitive landscape.

Pipeline Watch: R&D progress for essential competitor data and drug strategy development
Emerging Company Profiles: leading-edge companies exploring new trends and technologies
M&A and Deals: in-depth analysis and round ups of partnerships, licensing and acquisitions across the biopharma sector
Trend Spotting: in-market access, pipeline reviews, and more
Executive Interviews: with key opinion leaders, decision-makers and industry experts
Exclusive Market Forecasts: using Citeline proprietary databases including Datamonitor Healthcare, Biomedtracker, Pharmapremia and more
Financing: comprehensive analysis of venture funding, public offerings and start-up financing

What's included

Uncover current market dynamics

Assess information including successful and at-risk drug classes, market opportunity, threat of substitution and payer pressure.

Insight beyond the headlines

Understand the strategic implications of global commercial pharma news and their potential impact on your business.

Unparalleled access to data and decision-makers

Gain access to best-in class proprietary data as well as exclusive insight from industry leaders.

Powerful digital platform

Enjoy robust search functionality and the ability to create custom email alerts.

Our experts

Citeline’s award-winning publications provide in-depth coverage of the pharmaceutical industry, thanks to 65 in-house journalists who tackle the tough issues with precision, persistence and passion.

We provide comprehensive industry news, on areas ranging from pharmaceutical regulation and policy to generics and the medtech industry.

Our 300+ analysts are trusted advisers to a broad spectrum of the industry, including biopharma, biotechs, financial and professional services, CDMOs and CROs.